Sanofi

NASDAQ:SNY

Drug Manufacturers - General

Healthcare
$47.12 -0.73%

-$0.31 today

Market cap
$113.15B
Beta
0.28
P/E (TTM)
8.5
EPS (TTM)
$8.60
Dividend yield
5.62%
52W Low $41.86High $52.68

Volume 2.32M

Average 2.78M

SNY Total Debt

Short-term and long-term borrowings combined.

SanofiNASDAQ: SNY

Total Debt · Q2 FY2026 · quarter ended Jun 2026

Total debt rises 5.8% from a year ago

Total debt stood at €23.58B at the end of Q2 FY2026, up 5.8% from a year earlier and up 17.8% from the prior quarter. Over 3 fiscal years it compounded at -1.4% a year.

Context

  • Total debt amounted to 18.3% of total assets at the end of Q2 FY2026, up 0.4 pp from a year earlier.
  • Total debt increased in 1 of the last 3 fiscal years.

What to watch

Whether total debt keeps rising in the next quarterly balance sheet after a +5.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
€23.58B+17.8% QoQ
Last fiscal yearDec 2025
€20.33B+13.5% YoY
Year agoJun 2025
€22.29B+5.8% since
Total Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.8%——
1 year+13.5%——
3-year CAGR-1.4%——
5-year CAGR——
10-year CAGR——

Total Debt history

EUR · from the balance sheet

Latest · FY2025
20.33B EUR
Year-over-year change
+13.5%
4-year CAGR
-2.4%

Total Debt vs competitors

How SNY compares with its peers on the latest reported figures

  • Peers report in different currencies, so total debt is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +5.8% is the 5th highest of 11, against a peer median of +4.9%.
  • Total debt amounts to 18.3% of total assets for SNY, versus a peer median of 39.4%.
SNY Competitors
Total Debt for SNY and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
NVONovo Nordisk A/SJun 2026DKK 140.13B DKK+41.2%+71.9%23.6%
PFEPfizer Inc.Jun 2026$63.19B USD+2.3%+24.6%31.4%
AMGNAmgen Inc.Jun 2026$57.3B USD+2.0%+11.9%59.9%
LLYEli Lilly and CompanyJun 2026$54.91B USD+37.6%+37.8%38.6%
MRKMerck & Co., Inc.Jun 2026$53.91B USD+52.3%+16.5%41.5%
NVSNovartis AGJun 2026$49.01B USD+50.2%+9.9%40.2%
BMYBristol-Myers Squibb CompanyJun 2026$43.12B USD-15.3%+5.0%49.2%
AZNAstraZeneca PLCSep 2026$34.13B USD+4.5%+0.6%28.5%
GILDGilead Sciences, Inc.Jun 2026$26.25B USD+5.2%-0.4%53.2%
SNYSanofiJun 2026€23.58B EUR+5.8%-1.4%18.3%
GSKGSK plcJun 2026£18.13B GBP-23.8%-5.5%29.5%
Peer median (excluding SNY) —+4.9%+10.9%39.4%

Competitors are the stored peer set for SNY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents10.1B12.74B8.71B7.44B7.66B
Short-term Investments000486M810M
Net Receivables9.79B10.75B11.04B10.63B11.05B
Inventory8.72B8.96B9.67B9.43B10.21B
Other Current Assets1.35B870M471M13.71B307M
Total Current Assets30.56B34.03B30.66B42.59B30.95B
Property, Plant & Equipment (Net)11.98B11.68B11.81B11.6B11.51B
Goodwill48.06B49.89B49.4B43.38B41.3B
Intangible Assets21.41B21.64B24.32B22.63B26.26B
Long-term Investments2.91B3.22B3.26B3.26B6.61B
Tax Assets4.6B5.38B6.43B7.97B8.61B
Other Non-current Assets731M882M588M1.37B1.56B
Total Non-current Assets89.68B92.7B95.81B90.21B95.85B
Total Assets120.24B126.72B126.46B132.8B126.81B
Account Payables6.18B6.81B7.33B7.55B7.36B
Short-term Debt3.45B4.45B2.32B4.21B4.34B
Tax Payables309M574M597M1.13B0
Deferred Revenue319M264M000
Other Current Liabilities10.61B11.86B11.57B15.13B14.69B
Total Current Liabilities21.3B23.96B24.19B29.16B28.35B
Long-term Debt17.12B14.86B14.35B11.79B14.25B
Deferred Tax Liabilities1.62B1.84B1.86B2.17B1.67B
Deferred Revenue (Non-current)00000
Other Non-current Liabilities9.34B9B9.96B10.18B9.37B
Total Non-current Liabilities29.92B27.61B27.92B25.78B26.75B
Total Liabilities51.21B51.57B52.11B54.94B55.1B
Common Stock2.53B2.52B2.53B2.53B2.44B
Retained Earnings63.01B66.73B67.5B00
Accumulated OCI3.55B6.11B4.88B70.56B64.44B
Other Stockholders Equity0005.26B5.57B
Minority Interest350M368M313M350M334M
Total Equity69.03B75.15B74.35B77.86B71.71B
Total Debt22.41B21.21B18.7B17.91B20.33B
Net Debt12.32B8.48B9.99B10.47B12.67B

Sanofi

NASDAQ:SNY

Intrinsic Alpha fair value

Locked

Current Price

$47.12

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.